CIAS
TRIB

Capital Investment Advisory Services’s Trinity Biotech TRIB Stock Holding History

Capital Investment Advisory Services’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$2K – 1465
2019
Q2 		$2K Buy
+200
New +$2.38K ﹤0.01% 1304

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Capital Investment Advisory Services's TRIB Position: Q3 2019 in Review

Capital Investment Advisory Services sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 200 shares — an estimated $2K sold.

Capital Investment Advisory Services first reported a position in TRIB in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 29 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

  • Capital Investment Advisory Services reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 200 Trinity Biotech shares in Q3 2019, an estimated $2K.
  • Capital Investment Advisory Services first reported a position in Trinity Biotech in Q2 2019 and held it in 1 quarter.
  • Capital Investment Advisory Services's Trinity Biotech position peaked at $2K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on Capital Investment Advisory Services's 13F filing for Q3 2019, filed 17 Oct 2019.